Skip to main content
Intermediate Technical IVT

hyperinsulinemia

Pronunciation: HY-per-in-su-lin-EE-mee-ah

Elevated blood insulin levels, typically resulting from insulin resistance and serving as an early marker of metabolic dysfunction.

Full Definition

Hyperinsulinemia refers to abnormally high circulating insulin concentrations, most commonly occurring as a compensatory response to insulin resistance in peripheral tissues. This condition often precedes the development of type 2 diabetes by years or decades, as pancreatic beta cells increase insulin secretion to maintain normal glucose levels despite reduced tissue sensitivity. Hyperinsulinemia is associated with numerous adverse health effects including increased cardiovascular risk, hypertension, dyslipidemia, and promotion of certain cancers. It can be measured through fasting insulin levels or during glucose tolerance tests. The condition is central to the pathophysiology of metabolic syndrome and represents an important therapeutic target in preventing progression to overt diabetes.

Usage

Usage note: Distinguish from hyperglycemia (high glucose) and insulin resistance (reduced insulin sensitivity).

In Context

  • "The patient's hyperinsulinemia suggested early insulin resistance despite normal glucose tolerance." — Endocrinology consultation
  • "Lifestyle interventions can effectively reduce hyperinsulinemia in patients with prediabetes." — Diabetes prevention study

Also known as

elevated insulin levels insulin excess

Contrasted with

hypoinsulinemia insulin deficiency

Don't confuse with

insulin resistance hyperglycemia

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON